In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Editas Medicine Inc (NASDAQ: EDIT) was $1.42 for the day, up 0.71% from the previous closing price of $1.41. In other words, the price has increased by $0.71 from its previous closing price. On the day, 1.75 million shares were traded. EDIT stock price reached its highest trading level at $1.45 during the session, while it also had its lowest trading level at $1.32.
Ratios:
Our analysis of EDIT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.13.
Stifel Downgraded its Buy to Hold on December 13, 2024, whereas the target price for the stock was revised from $11 to $3.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 03 ’24 when O’Neill Gilmore Neil sold 1,618 shares for $2.08 per share. The transaction valued at 3,361 led to the insider holds 312,106 shares of the business.
Mei Baisong sold 541 shares of EDIT for $1,124 on Dec 03 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 133,354 shares after completing the transaction at $2.08 per share. On Sep 04 ’24, another insider, Mei Baisong, who serves as the EVP, CHIEF MEDICAL OFFICER of the company, sold 518 shares for $3.42 each. As a result, the insider received 1,774 and left with 133,895 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 117218296 and an Enterprise Value of -109381696. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.90 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at -1.771 whereas that against EBITDA is 0.491.
Stock Price History:
The Beta on a monthly basis for EDIT is 1.95, which has changed by -0.799431 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $11.58, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -17.58%, while the 200-Day Moving Average is calculated to be -62.85%.
Shares Statistics:
EDIT traded an average of 2.74M shares per day over the past three months and 2527340 shares per day over the past ten days. A total of 82.54M shares are outstanding, with a floating share count of 81.78M. Insiders hold about 0.93% of the company’s shares, while institutions hold 67.71% stake in the company. Shares short for EDIT as of 1736899200 were 19150654 with a Short Ratio of 6.99, compared to 1734048000 on 16929351. Therefore, it implies a Short% of Shares Outstanding of 19150654 and a Short% of Float of 29.38.
